Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sherman

Showing results (621-630 of 825) with videos related to

Pageof 83
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 26, 2024
Exploring the Utility of a Functional Magnetic Resonance Imaging Cannabis Cue-Reactivity Paradigm in Treatment-Seeking Adults With Cannabis Use DisorderGregory L Sahlem, Logan T Dowdle, Nathaniel L Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Using patients as their own controls for cost evaluation of phase I clinical trialsEric J Sherman, David M Rubin, Ennapadam Venkatraman, et al.
International Journal of Molecular Sciences|March 13, 2024
Evaluating Temperature Effects on Bluetongue Virus Serotype 10 and 17 Coinfection in <i>Culicoides sonorensis</i>Molly Carpenter, Jennifer Kopanke, Justin Lee, et al.
World Neurosurgery|October 28, 2023
Early Postoperative Seizures Following Awake Craniotomy and Functional Brain Mapping for LesionectomyBrin E Freund, Anteneh M Feyissa, Aafreen Khan, et al.
The Journal of Pain|October 18, 2017
Comparing Pain and Depressive Symptoms of Chronic Opioid Therapy Patients Receiving Dose Reduction and Risk Mitigation Initiatives With Usual CareManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infectionJuliana Bragazzi Cunha, Kyle Leix, Emily J Sherman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2024
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
The International Journal on Drug Policy|July 1, 2017
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiativesMichael Von Korff, Rod L Walker, Kathleen Saunders, et al.
Pain Medicine (Malden, Mass.)|December 9, 2017
Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse OutcomesManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Pageof 83

Showing results (621-630 of 825) with videos related to

Sort By:
Pageof 83
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 26, 2024
Exploring the Utility of a Functional Magnetic Resonance Imaging Cannabis Cue-Reactivity Paradigm in Treatment-Seeking Adults With Cannabis Use DisorderGregory L Sahlem, Logan T Dowdle, Nathaniel L Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Using patients as their own controls for cost evaluation of phase I clinical trialsEric J Sherman, David M Rubin, Ennapadam Venkatraman, et al.
International Journal of Molecular Sciences|March 13, 2024
Evaluating Temperature Effects on Bluetongue Virus Serotype 10 and 17 Coinfection in <i>Culicoides sonorensis</i>Molly Carpenter, Jennifer Kopanke, Justin Lee, et al.
World Neurosurgery|October 28, 2023
Early Postoperative Seizures Following Awake Craniotomy and Functional Brain Mapping for LesionectomyBrin E Freund, Anteneh M Feyissa, Aafreen Khan, et al.
The Journal of Pain|October 18, 2017
Comparing Pain and Depressive Symptoms of Chronic Opioid Therapy Patients Receiving Dose Reduction and Risk Mitigation Initiatives With Usual CareManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infectionJuliana Bragazzi Cunha, Kyle Leix, Emily J Sherman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2024
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
The International Journal on Drug Policy|July 1, 2017
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiativesMichael Von Korff, Rod L Walker, Kathleen Saunders, et al.
Pain Medicine (Malden, Mass.)|December 9, 2017
Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse OutcomesManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Pageof 83